The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19.

David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19.

Related Article(s):

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

One of the most contentious issues relating to COVID-19 is when to reopen schools. This is a complicated matter because placing people in close quarters risks spread of the disease. Yet children being at home makes it difficult for their working parents to manage their affairs and can potentially affect the learning experience. JAMA Associate Editor Preeti Malani, MD, chief health officer for the University of Michigan, discusses school reopening and how the University of Michigan is addressing this problem.

Related Article:

Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US

Harvey W. Kaufman, MD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study examining changes in the number of patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic in the United States.

Read the article here: https://ja.ma/31khw7X.

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Soumya Swaminathan, MD, DNB, chief scientist at the World Health Organization (WHO), discusses the global coronavirus pandemic and the WHO response. Recorded August 5, 2020.

Related Article:

COVID-19 Reveals Urgent Need to Strengthen the World Health Organization

Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020.

Related Article(s):

Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism

Few treatments have proven to be effective for treating COVID-19. Recently, a clinical trial reporting the results of dexamethasone for treating COVID-19 was published and has received a great deal of attention in the popular media. Greg Curfman, MD, JAMA Deputy Editor, reviews the study and discusses what the findings do or do not reveal about the efficacy of dexamethasone for treating COVID-19.

Related Article(s):

Missed Opportunities on Emergency Remdesivir Use

Roberta L. Schwartz, PhD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study examining rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among asymptomatic health care workers and community residents in the greater Houston, Texas, area.

Read the article here: https://ja.ma/3f8lvcz.

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Interview with Madeline R. Sterling, MD, author of Experiences of Home Health Care Workers in New York City During the Coronavirus Disease 2019 Pandemic: A Qualitative Analysis, and Theresa A. Allison, MD, PhD, author of Extreme Vulnerability of Home Care Workers During the COVID-19 Pandemic—A Call to Action

US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020.

Related Article:

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020.

Related Article:

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)